Lowell E. Sears
Chief Executive Officer at Sears Capital Management, Inc.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Robert Baumgartner | M | 68 | 21 years | |
Shigetoshi Matsumoto | M | 74 | 7 years | |
William Reed | M | - |
Cellerant Therapeutics, Inc.
Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Cellerant Therapeutics, Inc. develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer. The firm focuses on curative therapies for seriously ill patients and is developing a cell-based medicine as a treatment for chemotherapy and radiation-induced neutropenia as well as for Acute Radiation Syndrome. The company was founded by Irving L. Weissman in 2003 and is headquartered in San Carlos, CA. | 11 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Hiroki Maekawa | M | 56 | - | |
Kenji Murata | M | 55 | - | |
Martin Simonetti | M | 66 | 14 years | |
Eckard Weber | M | 73 |
Novalar Pharmaceuticals, Inc.
Novalar Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Novalar Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. It focuses on dental products. The company's OraVerse product (phentolamine mesylate) reverses the effects of local anesthetic with a vasoconstrictor and accelerates the return of normal sensation and function. The company was founded in 2000 and is headquartered in San Diego, CA.
Peninsula Pharmaceuticals, Inc.
Peninsula Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Peninsula Pharmaceuticals, Inc. used to develop and commercialize antibiotics to treat life threatening infections. The company used to develop optimal anti-infective therapies that offer improved efficacy, dosing and safety characteristics over existing therapies. It was founded in 2001. The company was located in Alameda, CA. | 11 years |
Dennis Podlesak | M | 66 |
Peninsula Pharmaceuticals, Inc.
Peninsula Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Peninsula Pharmaceuticals, Inc. used to develop and commercialize antibiotics to treat life threatening infections. The company used to develop optimal anti-infective therapies that offer improved efficacy, dosing and safety characteristics over existing therapies. It was founded in 2001. The company was located in Alameda, CA. | 2 years |
Michael V. Swanson | M | 69 |
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Vital Therapies, Inc. operates as a biotherapeutic company, which develops a cell-based therapy targeting the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. The company was founded in May 2003 and is headquartered in San Diego, CA. | 6 years |
Kevin Sharer | M | 76 | 20 years | |
Muneer Satter | M | 63 |
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Vital Therapies, Inc. operates as a biotherapeutic company, which develops a cell-based therapy targeting the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. The company was founded in May 2003 and is headquartered in San Diego, CA. | 6 years |
Osamu Ogawa | M | 75 | - | |
Terence E. Winters | M | 82 |
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Vital Therapies, Inc. operates as a biotherapeutic company, which develops a cell-based therapy targeting the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. The company was founded in May 2003 and is headquartered in San Diego, CA. | 14 years |
Faheem Hasnain | M | 65 |
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Vital Therapies, Inc. operates as a biotherapeutic company, which develops a cell-based therapy targeting the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. The company was founded in May 2003 and is headquartered in San Diego, CA. | 3 years |
Kazuo Asakawa | M | 70 | - | |
Daniel Vitt | M | 55 |
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Vital Therapies, Inc. operates as a biotherapeutic company, which develops a cell-based therapy targeting the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. The company was founded in May 2003 and is headquartered in San Diego, CA. | - |
Peter García | M | 62 | 14 years | |
John P. Walker | M | 75 |
Novacea, Inc.
Novacea, Inc. Pharmaceuticals: MajorHealth Technology Novacea, Inc. is a privately held biopharmaceutical company focused on licensing, developing and commercializing novel agents to revolutionize the treatment of cancer. Novacea’s in-licensed product portfolio features three clinical stage oncology therapeutics. The Company has two products which are anticipated to commence Phase 3 clinical trials in 2006, DN-101 and vinorelbine oral. Banoxantrone (AQ4N) is in Phase 1/2 clinical trials. It is located in South San Francisco, CA. | 3 years |
Harry Hixson | M | 84 | 6 years | |
Akira Suzuki | M | - | - | |
Thomas Miller | M | 69 |
CoCensys, Inc.
CoCensys, Inc. Pharmaceuticals: MajorHealth Technology CoCensys, Inc. discovers and develops drugs to treat neurological and psychiatric disorders. The company's product development programs focus on two novel and proprietary classes of compounds: Epalons, to treat epilepsy, migraine, anxiety and sleep disorders and Excitatory Amino Acid (EAA) receptor antagonists, to treat stroke, head trauma, epilepsy and Parkinson's disease. The company was founded in 1989 and is located in Irvine, CA. | 2 years |
Bradford Goodwin | M | 69 |
Novacea, Inc.
Novacea, Inc. Pharmaceuticals: MajorHealth Technology Novacea, Inc. is a privately held biopharmaceutical company focused on licensing, developing and commercializing novel agents to revolutionize the treatment of cancer. Novacea’s in-licensed product portfolio features three clinical stage oncology therapeutics. The Company has two products which are anticipated to commence Phase 3 clinical trials in 2006, DN-101 and vinorelbine oral. Banoxantrone (AQ4N) is in Phase 1/2 clinical trials. It is located in South San Francisco, CA. | 5 years |
J. Michael Millis | M | 65 |
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Vital Therapies, Inc. operates as a biotherapeutic company, which develops a cell-based therapy targeting the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. The company was founded in May 2003 and is headquartered in San Diego, CA. | 12 years |
William Ashton | M | 73 | 16 years | |
Donna Janson | F | - |
Novalar Pharmaceuticals, Inc.
Novalar Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Novalar Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. It focuses on dental products. The company's OraVerse product (phentolamine mesylate) reverses the effects of local anesthetic with a vasoconstrictor and accelerates the return of normal sensation and function. The company was founded in 2000 and is headquartered in San Diego, CA. | 7 years |
Laura A. Navalta | F | - |
Novalar Pharmaceuticals, Inc.
Novalar Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Novalar Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. It focuses on dental products. The company's OraVerse product (phentolamine mesylate) reverses the effects of local anesthetic with a vasoconstrictor and accelerates the return of normal sensation and function. The company was founded in 2000 and is headquartered in San Diego, CA. | 7 years |
Timothy M. Heaney | M | 78 | 3 years | |
David M. DeSonier | M | 66 |
Atlantic Richfield Co., Inc.
Atlantic Richfield Co., Inc. Integrated OilEnergy Minerals Atlantic Richfield Co. provides oil and gas extraction and production services . The firm's exploration and production operations are focused primarily in the Gulf of Mexico and the midcontinent in the United States, the United Kingdom North Sea, Indonesia, China and Algeria. The company was incorporated on April 15, 1985 and is headquartered in Warrenville, IL. | 20 years |
Douglas Godshall | M | 59 |
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Vital Therapies, Inc. operates as a biotherapeutic company, which develops a cell-based therapy targeting the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. The company was founded in May 2003 and is headquartered in San Diego, CA. | 5 years |
Dirk Thye | M | 54 |
Peninsula Pharmaceuticals, Inc.
Peninsula Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Peninsula Pharmaceuticals, Inc. used to develop and commercialize antibiotics to treat life threatening infections. The company used to develop optimal anti-infective therapies that offer improved efficacy, dosing and safety characteristics over existing therapies. It was founded in 2001. The company was located in Alameda, CA. | 4 years |
John G. Curd | M | 78 |
Novacea, Inc.
Novacea, Inc. Pharmaceuticals: MajorHealth Technology Novacea, Inc. is a privately held biopharmaceutical company focused on licensing, developing and commercializing novel agents to revolutionize the treatment of cancer. Novacea’s in-licensed product portfolio features three clinical stage oncology therapeutics. The Company has two products which are anticipated to commence Phase 3 clinical trials in 2006, DN-101 and vinorelbine oral. Banoxantrone (AQ4N) is in Phase 1/2 clinical trials. It is located in South San Francisco, CA. | 6 years |
John Dunn | M | 72 |
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Vital Therapies, Inc. operates as a biotherapeutic company, which develops a cell-based therapy targeting the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. The company was founded in May 2003 and is headquartered in San Diego, CA. | 5 years |
George A. Vandeman | M | 84 | 3 years | |
Takihiro Hirasawa | M | - | - | |
Cheryl Cohen | F | 58 |
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Vital Therapies, Inc. operates as a biotherapeutic company, which develops a cell-based therapy targeting the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. The company was founded in May 2003 and is headquartered in San Diego, CA. | 4 years |
Russell Cox | M | 60 |
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Vital Therapies, Inc. operates as a biotherapeutic company, which develops a cell-based therapy targeting the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. The company was founded in May 2003 and is headquartered in San Diego, CA. | 1 years |
David L. Urdal | M | 74 | 20 years | |
Masahiko Goto | M | - | - | |
Gil Omenn | M | 83 | 27 years | |
George Morstyn | M | 73 | 11 years | |
Gisela Schwab | M | 67 |
Cellerant Therapeutics, Inc.
Cellerant Therapeutics, Inc. Medical SpecialtiesHealth Technology Cellerant Therapeutics, Inc. develops stem cell-based cellular and antibody therapeutics for blood disorders and cancer. The firm focuses on curative therapies for seriously ill patients and is developing a cell-based medicine as a treatment for chemotherapy and radiation-induced neutropenia as well as for Acute Radiation Syndrome. The company was founded by Irving L. Weissman in 2003 and is headquartered in San Carlos, CA. | 17 years |
Susan Lundeen Smuck | F | 57 | 12 years | |
Errol Halperin | M | 83 |
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Vital Therapies, Inc. operates as a biotherapeutic company, which develops a cell-based therapy targeting the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. The company was founded in May 2003 and is headquartered in San Diego, CA. | 6 years |
Jean-Jacques Bienaimé | M | 70 |
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Vital Therapies, Inc. operates as a biotherapeutic company, which develops a cell-based therapy targeting the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. The company was founded in May 2003 and is headquartered in San Diego, CA. | 5 years |
Alan C. Mendelson | M | 76 | 1 years | |
Manfred Gröppel | M | 55 |
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Vital Therapies, Inc. operates as a biotherapeutic company, which develops a cell-based therapy targeting the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. The company was founded in May 2003 and is headquartered in San Diego, CA. | - |
Brian H. Dovey | M | 83 |
Novalar Pharmaceuticals, Inc.
Novalar Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Novalar Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. It focuses on dental products. The company's OraVerse product (phentolamine mesylate) reverses the effects of local anesthetic with a vasoconstrictor and accelerates the return of normal sensation and function. The company was founded in 2000 and is headquartered in San Diego, CA. | - |
Gerardo Canet | M | 78 | 17 years | |
Louis P. Eatman | M | - |
Stanford Graduate School of Business
| 2 years |
Mitch Fisher | M | 74 |
Claremont McKenna College
| 4 years |
Danute M. Bankaitis-Davis | M | - | 6 years | |
Keith L. Klein | M | 60 | 15 years | |
William Marshall | M | 60 | 10 years | |
Frederick A. Fletcher | M | - | 10 years | |
Phil McMahon | M | - | - | |
Steven J. Roy | M | - | 13 years | |
Henry R. Appelbaum | M | - | 9 years | |
Andrew Knudten | M | - | 13 years | |
Lawrence J. Casarta | M | - |
Atlantic Richfield Co., Inc.
Atlantic Richfield Co., Inc. Integrated OilEnergy Minerals Atlantic Richfield Co. provides oil and gas extraction and production services . The firm's exploration and production operations are focused primarily in the Gulf of Mexico and the midcontinent in the United States, the United Kingdom North Sea, Indonesia, China and Algeria. The company was incorporated on April 15, 1985 and is headquartered in Warrenville, IL. | 19 years |
Kevin L. Stark | M | - | 15 years | |
David A. Boyden | M | 63 | 13 years | |
MacDonald Hawley | M | - |
Claremont McKenna College
| 4 years |
Nancy T. Schmitt | F | - |
Atlantic Richfield Co., Inc.
Atlantic Richfield Co., Inc. Integrated OilEnergy Minerals Atlantic Richfield Co. provides oil and gas extraction and production services . The firm's exploration and production operations are focused primarily in the Gulf of Mexico and the midcontinent in the United States, the United Kingdom North Sea, Indonesia, China and Algeria. The company was incorporated on April 15, 1985 and is headquartered in Warrenville, IL. | 11 years |
Peter K. Watler | M | 62 | 12 years | |
Jaime Nassar | M | - |
Novalar Pharmaceuticals, Inc.
Novalar Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Novalar Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. It focuses on dental products. The company's OraVerse product (phentolamine mesylate) reverses the effects of local anesthetic with a vasoconstrictor and accelerates the return of normal sensation and function. The company was founded in 2000 and is headquartered in San Diego, CA. | 2 years |
Nick Abbott | M | - | 10 years | |
Timothy Bliss | M | 71 |
Stanford Graduate School of Business
| 2 years |
Denny Lanfear | M | 68 | 13 years | |
Roger Deromedi | M | 70 |
Stanford Graduate School of Business
| 2 years |
Steve Lazarus | M | - | 17 years | |
Margaret E. Valeur-Jensen | M | 67 | 7 years | |
David Alan Goodkin | M | - | 10 years | |
Kurt Lauk | M | 76 |
Stanford Graduate School of Business
| 2 years |
Diane M. Palumbo | F | 70 | 12 years | |
Allan B. Golad | M | 69 |
Claremont McKenna College
| 4 years |
Bill H. Younger | M | 74 |
Stanford Graduate School of Business
| 2 years |
Susan Mahony | M | 59 | 4 years | |
Wesley Clark | M | 72 |
Stanford Graduate School of Business
| 2 years |
Aries Crown | M | 72 |
Claremont McKenna College
| 4 years |
Tania Amochaev | F | 73 |
Stanford Graduate School of Business
| 1 years |
A. Michael Spence | M | 79 |
Stanford Graduate School of Business
| 15 years |
Tom C. Tinsley | M | 71 |
Stanford Graduate School of Business
| 2 years |
Steven A. Denning | M | 75 |
Stanford Graduate School of Business
| 2 years |
Katherine August-deWilde | F | 75 |
Stanford Graduate School of Business
| 2 years |
Keith Leonard | M | 62 | 13 years | |
Mark Moon | M | - | 6 years | |
Rosemary Mazanet | M | 68 | 5 years | |
Steve Baloff | M | 68 |
Stanford Graduate School of Business
| 4 years |
Robert Badcon Thompson | M | - |
Stanford Graduate School of Business
| 2 years |
Amjad Bseisu | M | 60 |
Atlantic Richfield Co., Inc.
Atlantic Richfield Co., Inc. Integrated OilEnergy Minerals Atlantic Richfield Co. provides oil and gas extraction and production services . The firm's exploration and production operations are focused primarily in the Gulf of Mexico and the midcontinent in the United States, the United Kingdom North Sea, Indonesia, China and Algeria. The company was incorporated on April 15, 1985 and is headquartered in Warrenville, IL. | 14 years |
Mou-daid Cha | M | 72 |
Stanford Graduate School of Business
| 2 years |
Daniel M. Neidich | M | 74 |
Stanford Graduate School of Business
| 2 years |
Donald Dixon | M | 76 |
Stanford Graduate School of Business
| 2 years |
David Hallal | M | 56 | 10 years | |
Jody Lindell | F | 72 |
Stanford Graduate School of Business
| 2 years |
José Miguel Morales Dasso | M | 79 |
Stanford Graduate School of Business
| 4 years |
Wes Wada | M | - |
Atlantic Richfield Co., Inc.
Atlantic Richfield Co., Inc. Integrated OilEnergy Minerals Atlantic Richfield Co. provides oil and gas extraction and production services . The firm's exploration and production operations are focused primarily in the Gulf of Mexico and the midcontinent in the United States, the United Kingdom North Sea, Indonesia, China and Algeria. The company was incorporated on April 15, 1985 and is headquartered in Warrenville, IL. | 20 years |
Tom Goodrich | M | - |
Stanford Graduate School of Business
| 2 years |
Stephen H. Watkins | M | - | 6 years | |
Donna French | M | 59 | 15 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 91 | 91.00% |
Japan | 10 | 10.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Lowell E. Sears
- Personal Network